CCL2 and myeloid sarcoma: Almost unique among inflammatory chemokines, generally up-regulated, CCL2 is consistently present at lower levels in the CSF (and often in the blood) of MS patients compared to healthy controls (HC) or patients with other non-inflammatory diseases.